AbCellera is a biotechnology company based in Cambridge, MA, dedicated to developing innovative antibody medicines for patients. They collaborate with leading pharmaceutical companies and utilize cutting-edge technologies to advance their internal pipeline of programs, focusing on a wide range of therapeutic areas including cancer, metabolic conditions, pain, and autoimmunity.
Their team of scientists, engineers, creatives, and business professionals is committed to pushing the boundaries of science and technology to bring better therapies to patients. By fostering a collaborative and purpose-driven environment, AbCellera aims to make a meaningful impact on global health through their groundbreaking antibody discovery and development efforts.
Generated from the website